Page 1720 - Hematology_ Basic Principles and Practice ( PDFDrive )

1530 Part IX Cell-Based Therapies

transplantation: guidelines from the American Society for Blood and Rowley SD, Yu J, Heimfeld S, et al: Trafficking of CD34+ cells into the
Marrow Transplantation. Biol Blood Marrow Transplant 20(9):1262–1273, peripheral circulation during collection of peripheral blood stem cells by
2014. apheresis. Bone Marrow Transplant 28(7):649–656, 2001.
Giralt S, Costa L, Schriber J, et al: Optimizing autologous stem cell mobiliza- Sacchi N, Costeas P, Hartwell L, et al: Haematopoietic stem cell donor
tion strategies to improve patient outcomes: consensus guidelines and registries: World Marrow Donor Association recommendations for evalu-
recommendations. Biol Blood Marrow Transplant 20(3):295–308, 2014. ation of donor health. Bone Marrow Transplant 42(1):9–14, 2008.
Heimfeld S: HLA-identical stem cell transplantation: is there an optimal Sharma M, Afrin F, Satija N, et al: Stromal-derived factor-1/CXCR4 signal-
CD34 cell dose? Bone Marrow Transplant 31(10):839–845, 2003. ing: indispensable role in homing and engraftment of hematopoietic stem
Horowitz MM, Confer DL: Evaluation of hematopoietic stem cell donors. cells in bone marrow. Stem Cells Dev 20(6):933–946, 2011.
Hematology Am Soc Hematol Educ Program 469–475, 2005. Solves P, Mirabet V, Perales A, et al: Banking strategies for improving the
Kao GS, Kim HT, Daley H, et al: Validation of short-term handling and hematopoietic stem cell content of umbilical cord blood units for trans-
storage conditions for marrow and peripheral blood stem cell products. plantation. Curr Stem Cell Res Ther 3(2):79–84, 2008.
Transfusion 51(1):137–147, 2011. Thomas ED, Storb R: Technique for human marrow grafting. Blood
Kurtzberg J, Cairo MS, Fraser JK, et al: Results of the Cord Blood Transplan- 36(4):507–515, 1970.
tation (COBLT) Study unrelated donor banking program. Transfusion To LB, Levesque J-P, Herbert KE: How I treat patients who mobilize hema-
45(6):842–855, 2005. topoietic stem cells poorly. Blood 118(17):4530–4540, 2011.
Malik S, Bolwell B, Rybicki L, et al: Apheresis days required for harvesting Weaver CH, Hazelton B, Birch R, et al: An analysis of engraftment kinetics
CD34+ cells predicts hematopoietic recovery and survival following as a function of the CD34 content of peripheral blood progenitor cell
autologous transplantation. Bone Marrow Transplant 46(12):1519–1525, collections in 692 patients after the administration of myeloablative
2011. chemotherapy. Blood 86(10):3961–3969, 1995.
Miller JP, Perry EH, Price TH, et al: Recovery and safety profiles of marrow Worel N, Buser A, Greinix HT, et al: Suitability criteria for adult related
and PBSC donors: experience of the National Marrow Donor Program. donors: a consensus statement from the Worldwide Network for Blood
Biol Blood Marrow Transplant 14(9 Suppl):29–36, 2008. and Marrow Transplantation (WBMT) Standing Committee on Donor
Morrison SJ, Scadden DT: The bone marrow niche for haematopoietic stem Issues. Biol Blood Marrow Transplant 2015. [Epub ahead of print].
cells. Nature 505(7483):327–334, 2014.
Pulsipher MA, Chitphakdithai P, Logan BR, et al: Acute toxicities of unre-
lated bone marrow versus peripheral blood stem cell donation: results of REFERENCES
a prospective trial from the National Marrow Donor Program. Blood
121(1):197–206, 2013. For the complete list of references, log on to www.expertconsult.com.